[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338648-105":59,"doc-detail-338648-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","molecular-research-and-treatment-of-urologic-cancer","Molecular Research and Treatment of Urologic Cancer","","Urologic cancers show tumor heterogeneity across morphology, gene expression, and phenotypic traits, producing variable responses to drug treatment. A special issue assembles five research articles and one review to clarify molecular mechanisms underlying prostate, renal (kidney), and bladder cancer, spanning gene-network links to prostate progression, photodynamic-therapy modulation by metalation, renal-cell carcinoma biomarkers involving 4PYR and MrgD, and bladder-cancer metastatic pathways such as the ERVK13/miR-873-5p/GNMT axis, plus treatment-improvement strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-research-and-treatment-of-urologic-cancer/338648/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-research-and-treatment-of-urologic-cancer/338648.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is understanding molecular heterogeneity important in urologic cancers?","Question",{"text":113,"@type":114},"Urologic cancers vary in morphology, gene expression, and phenotype, and these differences drive different responses to drug therapy. Clarifying the mechanisms of heterogeneity is presented as necessary to overcome therapeutic challenges for patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What types of studies are included in the special issue on urologic cancers?",{"text":118,"@type":114},"The issue collects five research articles and one review article focused on molecular mechanisms in prostate, renal, and bladder cancer.",{"name":120,"@type":111,"acceptedAnswer":121},"Which prostate cancer research direction is highlighted by gene-network analyses?",{"text":122,"@type":114},"A study correlates gene networks and pathways with tissue differentiation and links high Gleason scores to sensitivity to DNA damage, cell division, and telomere elongation using TCGA data.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338648,1790469199,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":24,"preview_page_count":14,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Editorial  \nMolecular Research and Treatment of Urologic Cancer  \nHironobu Yamashita  \nCitation: Yamashita, H. Molecular Research and Treatment of Urologic Cancer. Int. J. Mol. Sci. 2024, 25, 13666 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms252413666  \nReceived: 3 December 2024  \nRevised: 9 December 2024  \nAccepted: 15 December 2024  \nPublished: 20 December 2024  \nCopyright: © 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA; [hyamashita@pennstatehealth.psu.edu](hyamashita@pennstatehealth.psu.edu)  \nUrologic cancers exhibit tumor heterogeneity in their morphology, gene expression, and phenotypic features, and have different responses to drug treatment [1] . Thus, it is significant to elucidate the molecular mechanisms of heterogeneity to overcome this therapeutic problem for cancer patients.  \nTherefore, this Special Issue focuses on urologic cancers. Five research articles and one review article were collected in the Special Issue “Molecular Research and Treatment of Urologic Cancers” to understand the molecular mechanisms of prostate, renal (kidney), and bladder cancer.  \n(1) Prostate Cancer Research  \nFilippi et al. published a research article titled “Analysis of the gene networks and pathways correlated with tissue differentiation in prostate cancer”, which tried to correlate gene expression with the Gleason score of prostate cancer. Using The Cancer Genome Atlas (TCGA), a publicly available database of 497 prostate cancer specimens, the authors reported that high Gleason scores were linked to sensitivity to DNA damage, cell division, and telomere elongation. Their findings contribute to a deeper understanding of how gene expression relates to the progression and aggressiveness of PCa [2] .  \nPaulus et al. published a research article titled “The effect of photosensitizer metalation incorporated into arene–ruthenium assemblies on prostate cancer”. The various treatments for prostate cancer have several side effects. However, photodynamic therapy (PDT) has almost no adverse effects. This method uses a combination of photosensitizersand light to kill cells by inducing the generation of reactive oxygen species inside cells. This study investigated the role of metals, including magnesium, cobalt, and zinc, in photosensitizers used in this therapeutic method. The authors demonstrated that these metals can induce destructive effects in prostate cancer cell lines. However, the addition of metals to photosensitizers reduces the efficacy of PDT [3] .  \n(2) Renal Cancer Research  \nTwo research articles on renal cancer have been published.  \nJedrzejewska et al. published a research article titled “Elevated plasma concentration of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) highlights the malignancy of renal cell carcinoma”.  \nNicotinamide (NA) is a precursor compound of 4PYR that plays a significant role in multiple biological functions encompassing DNA repair mechanisms, cell cycle progression, and inflammatory processes. 4PYR was previously reported by these authors to be anoncometabolite in breast, lung, and bladder cancer. The authors reported that 4PYR could be an oncometabolite in the clear cell renal cell carcinoma (ccRCC) subtype and that elevated levels of 4PYR are highly correlated with tumor aggressiveness, mortality, recurrence, and metastasis in ccRCC patients. Their results showed 4PYR’s potential as an oncometabolitein the ccRCC subtype [4] .  \nLarrinaga et al. published a research article titled “The Expression of Alamandine Receptor MrgD in Clear Cell ","cbCaibdQjkUktX9J","https://ap.wps.com/l/cbCaibdQjkUktX9J","pdf",157809,"English","# Editorial\n## Urologic cancer heterogeneity and therapeutic need\n## Special Issue overview\n## Prostate Cancer Research\n## Renal Cancer Research\n## Bladder Cancer Research","[{\"question\":\"Why is understanding molecular heterogeneity important in urologic cancers?\",\"answer\":\"Urologic cancers vary in morphology, gene expression, and phenotype, and these differences drive different responses to drug therapy. Clarifying the mechanisms of heterogeneity is presented as necessary to overcome therapeutic challenges for patients.\"},{\"question\":\"What types of studies are included in the special issue on urologic cancers?\",\"answer\":\"The issue collects five research articles and one review article focused on molecular mechanisms in prostate, renal, and bladder cancer.\"},{\"question\":\"Which prostate cancer research direction is highlighted by gene-network analyses?\",\"answer\":\"A study correlates gene networks and pathways with tissue differentiation and links high Gleason scores to sensitivity to DNA damage, cell division, and telomere elongation using TCGA data.\"}]","Molecular Research and Treatment of Urologic Cancer | PDF",1790024780,[146,150],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eca45f96c8b9552ebfeebcaa592dd76f.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8dcc5d29212936a69e99caa75db75ff.webp",982,1388]